Lyophilized Bacterial Lysates Of: Haemophilus Influenzae Streptococcus (Diplococcus) Pneumoniae Klebsiella Pneumoniae And Ozaenae Staphylococcus Aureus Streptococcus Pyogenes And Viridans Moraxella (Branhamella / Neisseria) Catarrhalis

5 trials 2 recruiting RRespiratory

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

2 Completed trials

5 Sponsors

5 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 3

Sponsors using this IMP

OM Pharma SA 2 Fondazione Policlinico Universitario Campus Bio-medico In Forma A Bbreviata Fon 1 Semmelweis University 1 Sint Franciscus Vlietland Groep Stichting 1 University Of Pecs 1

All trials

5 total

The effect of Broncho-Vaxom on the COPD exacerbations in terms of lung function, lung mechanics, immune state, body composition, quality of … Pending

2025-524501-32-02 Phase IV 1 country Semmelweis University; University Of Pecs
Study of prevention of respiratory infections through the drug OM85 in elderly patients Recruiting

2024-513592-41-00 Phase IV 1 country Fondazione Policlinico Universitario Campus Bio-medico In Forma A Bbreviata Fon
Protecting late-moderate preterm infants from respiratory tract infections and wheeze in their first year of life by using bacterial lysates Recruiting

2024-518498-32-01 Phase III 1 country Sint Franciscus Vlietland Groep Stichting
A clinical study investigating OM-85 efficacy and safety in children suffering from Recurrent Wheezing Ended

2024-511083-90-00 Phase II 2 countries OM Pharma SA
OM 85 in Paediatric Recurrent Respiratory Tract Infections with Wheezing Lower Respiratory Illness Ended

2024-511581-37-00 Phase IV 4 countries OM Pharma SA

Showing 1–5 of 5 trials

← All drugs A–Z